文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

合并症对接受有创机械通气撤机患者管理和结局的影响:WEAN SAFE研究的启示

Impact of comorbidities on management and outcomes of patients weaning from invasive mechanical ventilation: insights from the WEAN SAFE study.
PubMed 文献 · Crit Care · 2025-03-13
一句话结论WEAN SAFE研究显示,合并症越多,有创机械通气撤机失败风险与住院死亡率越高,且此影响并非源于撤机策略更保守。

WEAN SAFE研究纳入4523例开始撤机流程的有创机械通气患者,按合并症数量(无、1、2、≥3)和类型分组。合并症越多,撤机失败比例逐步升高,神经肌肉合并症与撤机时间延长相关,呼吸、肝脏、肾脏、神经肌肉和免疫功能障碍合并症增加撤机失败。住院死亡率从无合并症的16%逐步升至≥3个合并症的34%,每种特定合并症均与住院死亡率独立相关;合并症的存在与限制生命维持干预的决策相关。结论提示多数撤机患者有合并症,合并症与更高撤机失败风险和更差结局相关,且不良影响不能由撤机策略更保守解释。

要点

  • 4523例开始撤机的患者中,65.5%存在至少1个合并症(1个35.7%、2个19.7%、≥3个9.6%),无合并症34.5%。
  • 住院死亡率随合并症数量从无合并症的16%逐步升至≥3个合并症的34%。
  • 每种特定合并症均与住院死亡率独立相关;呼吸、肝脏、肾脏、神经肌肉和免疫功能障碍合并症增加撤机失败。
  • 合并症患者更可能分离尝试失败、接受拔管尝试及需要超过1次拔管尝试;神经肌肉合并症与撤机时间延长相关。
  • 合并症对撤机结局和过程的不良影响不能由对撤机采取更保守的策略解释。

适用人群与场景

  • WEAN SAFE研究中开始撤机流程的有创机械通气患者,共4523例。

研究设计与关键结果

  • 研究类型为WEAN SAFE研究中的患者分析;共4523例开始撤机流程的有创机械通气患者;按合并症数量(无、1、2、≥3)和特定合并症类型分组。
  • 合并症分布:1个合并症1614例(35.7%),2个889例(19.7%),≥3个432例(9.6%),无合并症1562例(34.5%);最常见合并症为呼吸系统(22%)和心血管系统(11%)。
  • 合并症患者更可能分离尝试失败、接受拔管尝试及需要超过1次拔管尝试;有创机械通气撤机失败比例随合并症数量增加逐步升高。
  • 神经肌肉合并症与撤机时间延长相关;呼吸、肝脏、肾脏、神经肌肉和免疫功能障碍合并症增加撤机失败。
  • 住院死亡率从无合并症的16%逐步升至≥3个合并症的34%;每种特定合并症均与住院死亡率独立相关。
  • 合并症的存在与限制生命维持干预的决策相关。

证据类型、等级与局限

  • 证据类型:WEAN SAFE研究的患者分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,多数有创机械通气撤机患者存在合并症,合并症与更高撤机失败风险和更差结局相关。
  • 合并症对撤机结局和过程的不良影响不能由对撤机采取更保守的策略解释。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The impact of comorbidities on patients weaning from invasive ventilation is incompletely understood. We wished to understand the impact of the number and type of comorbidities on patients' weaning from invasive mechanical ventilation enrolled in the 'WorldwidE AssessmeNt of Separation of pAtients From ventilatory assistancE (WEAN SAFE) study.

METHODS: The study population consisted of patients enrolled in the WEAN SAFE study that commenced the weaning process. We categorized patients by the number of comorbidities (none, 1, 2, or 3 plus), and by specific comorbidity type. The primary outcome was the impact of comorbidities on delayed weaning and failed weaning from invasive MV. Secondary outcomes included the impact of comorbidities on ICU and hospital survival, and decisions to limit life-sustaining interventions.

RESULTS: Of 4523 patients in the study population, 1614 (35.7%) had one comorbidity, 889 (19.7%) had two comorbidities, 432 (9.6%) had three or more comorbidities, while 1562 (34.5%) had no comorbidities. The most frequently occurring comorbid conditions were respiratory (22%) and cardiovascular (11%). Patients with comorbidities were more likely to fail a separation attempt, more likely to receive an extubation attempt, and to require more than 1 extubation attempt. The proportion of patients with failed weaning from invasive MV increased progressively with increasing comorbidities. Neuromuscular comorbidities were associated with increased weaning duration. Weaning failure was increased with respiratory, hepatic, renal, neuromuscular, and immune dysfunction comorbidities. Hospital mortality rates increased progressively from 16% with no comorbidity to 34% with ≥ 3 comorbidities. Each specific comorbidity was independently associated with increased hospital mortality. The presence of comorbidities was associated with decisions to limit life sustaining interventions.

CONCLUSIONS: Most patients weaning from invasive ventilation have comorbidities, which are associated with higher weaning failure risk and worse outcomes. The adverse impact of comorbidities on the weaning outcomes and of the process are not explained by a less aggressive approach to weaning.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Khazaei O, Laffey CM, Sheerin R, et al. Impact of comorbidities on management and outcomes of patients weaning from invasive mechanical ventilation: insights from the WEAN SAFE study. Crit Care. 2025. PMID: 40082949. doi:10.1186/s13054-025-05341-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。